PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Reduced Operational Expenses and Consolidation Buoy the Brazilian Clinical Diagnostics Automation Market - With consolidations becoming the norm among clinical laboratories, the clinical diagnostics automation market is all set to witness substantial growth
Reduced Operational Expenses and Consolidation Buoy the Brazilian Clinical Diagnostics Automation Market

 

NewswireToday - /newswire/ - Sao Paulo, Brazil, 2008/03/27 - With consolidations becoming the norm among clinical laboratories, the clinical diagnostics automation market is all set to witness substantial growth.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The consolidation movement will cause an escalation in the number of tests for processing, which, in turn, will drive the clinical diagnostics automation market.

New analysis from Frost & Sullivan (pharma.frost.com), Brazilian Clinical Diagnostics Automation Markets, finds that the market earned revenues of $31.0 million in 2007 and estimates this to reach $49.5 million in 2012.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the Brazilian Clinical Diagnostics Automation Markets, then send an email to jjantus_pr[.]frost.com with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.

"Dealing with a massive number of samples is a time-consuming process and implies higher possibilities of error," says Tania Mito, Research Analyst at Frost & Sullivan. "Automation can alleviate this problem by optimizing the use of laboratory resources, resulting in faster and safer processes."

Moreover, in a consolidating market, automation could serve as a significant differentiation factor. Automation solutions can optimally use laboratory resources, help standardize procedures, and reduce human involvement. These competitive advantages will improve quality and speed of services, accuracy of results, and reliability of tests.

"Despite their advantages, budget restraints of the Brazilian healthcare market and the high initial investments required for automation technology has deterred several laboratories from adopting this technology," notes Mito. "In addition, end users do not fully appreciate the benefits of reduced labor requirements, since labor costs are extremely low in Brazil."

While the reduction of human resources was expected to compensate for the costs of automating laboratories in the United States and Europe, the concept of labor cost savings has not caught the fancy of investors in Brazil. Market participants can remedy this situation by promoting automation's long-term benefits such as safer and faster procedures as well as results that are more reliable.

"Automation is an excellent tool for reducing operational costs and enhancing productivity and efficiency," remarks Mito. "Processing larger quantities of samples and operating on the pre- and post-analytical stages will save costs through reductions in labor force and time, enabling the laboratory to optimize its resources."

End users should know about these advantages, if market participants wish to tap the full potential of the Brazilian market.

Brazilian Clinical Diagnostics Automation Markets is part of the Pharmaceutical & Biotechnology and of Drug Discovery Technologies & Clinical Diagnostics Growth Partnership Service programs, which also includes research in the following markets: global patient monitoring, global medical devices, global clinical diagnostics, global drug discovery technologies, and others. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Service, Growth Consulting, and Career Best Practices empower clients to create a growth focused culture that generates, evaluates, and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses, and the investment community from more than 30 offices on six continents.

Brazilian Clinical Diagnostics Automation Markets - N2C5

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Reduced Operational Expenses and Consolidation Buoy the Brazilian Clinical Diagnostics Automation Market

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: José María Jantus 
+54-11-4777- 9951 jose.jantus[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  1Click Games





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)